Fixed daily dose of a low molecular weight heparin compared with an adjusted dose of unfractionated heparin for treating blood clots in the deep veins

Venous thromboembolism is a common and potentially life-threatening condition in which a clot forms in the veins of the leg or pelvis or moves up to the lungs where it blocks a blood vessel. Heparin is one of the treatments and an updated Cochrane Review from February 2017 examines the evidence of its effects. Lindsay Robertson from the Freeman Hospital in Newcastle upon Tyne in the UK tells us about these latest findings.

Source: Podcasts from The Cochrane Library - June 7, 2017 Category: General Medicine Authors: Cochrane Source Type: podcasts